(Q63634125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

S Advani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Pai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Adde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Vaidya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Vats

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P A Kurkure

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C N Nair

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Venzon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

I Magrath

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

893-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Abdominal Burkitt-type lymphomas in Algeria

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228529397

7 January 2021

Identifiers

DOI

10.1023/A:1008228529397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9358941%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference